TippingPoint Biosciences
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer
$4.5MSeed
Role not disclosedSP
Sazze Partners
Activity from announced rounds
Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026
Sazze Partners is a Silicon Valley and Korean venture manager named independently by Airbility, F4GE and TippingPoint.
Recorded funding activity
Airbility develops aircraft and counter-drone systems. F4GE structures manufacturing data, while TippingPoint develops discovery methods for pediatric brain cancer. Shared branding does not establish a merger with a separately named Primer fund.
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $191.5M 2 disclosed · full round size, not this investor’s share